Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.
Cancer Science & Therapy has got h-index 27, which means every article in Cancer Science & Therapy has got 27 average citations.
Following are the list of articles that have cited the articles published in Cancer Science & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
Total published articles |
57 | 46 | 70 | 59 | 42 | 78 | 71 |
Research, Review articles and Editorials |
3 | 4 | 18 | 22 | 27 | 26 | 69 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
41 | 45 | 52 | 37 | 15 | 52 | 2 |
Conference proceedings |
0 | 21 | 45 | 12 | 0 | 162 | 404 |
Citations received as per Google Scholar, other indexing platforms and portals |
4129 | 3358 | 294 | 348 | 345 | 373 | 344 |
| Journal total citations count | 5332 |
| Journal impact factor | 2.06 |
| Journal 5 years impact factor | 2.85 |
| Journal cite score | 6.17 |
| Journal h-index | 27 |
| Journal h-index since 2019 | 18 |
Aljabery F, Lindblom G, Skoog S, Shabo I, Olsson H, Rosell J, Jahnson S. PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer. BMC urology. 2015 Dec;15(1):87. |
|
Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR. The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World journal of urology. 2016 Sep 1;34(9):1229-37. |
|
Bouchelouche K, Choyke PL. PET/computed tomography in renal, bladder, and testicular cancer. PET clinics. 2015 Jul 1;10(3):361-74. |
|
Goodfellow H, Viney Z, Hughes P, Rankin S, Rottenberg G, Hughes S, Evison F, Dasgupta P, O'brien T, Khan MS. Role of fluorodeoxyglucose positron emission tomography (FDG PET)â€Âcomputed tomography (CT) in the staging of bladder cancer. BJU international. 2014 Sep;114(3):389-95. |
|
Rahul J. Research and Reviews: Journal of Pharmaceutics and Nanotechnology. |
|
Azad MA. Journal of Medical and Health Sciences. |
|
Angelini P, Tirillini B, Akhtar MS, Dimitriu L, Bricchi E, Bertuzzi G, Venanzoni R. Essential Oil with Anticancer Activity: An Overview. InAnticancer Plants: Natural Products and Biotechnological Implements 2018 (pp. 207-231). Springer, Singapore. |
|
Tariq A, Sadia S, Pan K, Ullah I, Mussarat S, Sun F, Abiodun OO, Batbaatar A, Li Z, Song D, Xiong Q. A systematic review on ethnomedicines of antiâ€Âcancer plants. Phytotherapy Research. 2017 Feb;31(2):202-64. |
|
Kehler P. Entwicklung und Charakterisierung verschiedener neuartiger bispezifischer Antikörper basierend auf PankoMab-GEX™ zur Verbesserung der Tumortherapie. |
|
Hung JT, Alice LY. Targeting Glycans for Immunotherapy of Human Cancers. InGlycosignals in Cancer: Mechanisms of Malignant Phenotypes 2016 (pp. 197-219). Springer, Tokyo. |
|
Saeidnia S. Carbohydrates Against Cancer. InNew Approaches to Natural Anticancer Drugs 2015 (pp. 93-106). Springer, Cham. |
|
Yang CY, Lin MW, Chang YL, Wu CT. Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer. Cancer Biomarkers. 2017 Dec 12(Preprint):1-0. |
|
Pochechueva T, Alam S, Schötzau A, Chinarev A, Bovin NV, Hacker NF, Jacob F, Heinzelmann-Schwarz V. Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients. Journal of ovarian research. 2017 Dec;10(1):8. |
|
Ho MY, Alice LY, Yu J. Glycosphingolipid dynamics in human embryonic stem cell and cancer: their characterization and biomedical implications. Glycoconjugate journal. 2017 Dec 1;34(6):765-77. |
|
Kuo HH, Lin RJ, Hung JT, Hsieh CB, Hung TH, Lo FY, Ho MY, Yeh CT, Huang YL, Yu J, Alice LY. High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma. Scientific Reports. 2017 Sep 7;7(1):10750. |
|
Yu AL, Hung JT, Ho MY, Yu J. Alterations of glycosphingolipids in embryonic stem cell differentiation and development of glycan-targeting cancer immunotherapy. Stem cells and development. 2016 Oct 15;25(20):1532-48. |
|
Cheng SP, Yang PS, Chien MN, Chen MJ, Lee JJ, Liu CL. Aberrant expression of tumorâ€Âassociated carbohydrate antigen Globo H in thyroid carcinoma. Journal of surgical oncology. 2016 Dec;114(7):853-8. |
|
Saeidnia S. New approaches to natural anticancer drugs. Springer; 2015 Feb 5. |
|
Eller CH, Chao TY, Singarapu KK, Ouerfelli O, Yang G, Markley JL, Danishefsky SJ, Raines RT. Human cancer antigen globo H is a cell-surface ligand for human ribonuclease 1. ACS central science. 2015 Jul 13;1(4):181-90. |
|
Cheng JY, Wang SH, Lin J, Tsai YC, Yu J, Wu JC, Hung JT, Lin JJ, Wu YY, Yeh KT, Alice LY. Globo-H ceramide shed from cancer cells triggers translin-associated factor X-dependent angiogenesis. Cancer research. 2014 Oct 3. |
|
Cancer Science & Therapy received 5332 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 